CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
San Antonio, Texas, United States and 107 other locations
This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early...
Phase 4
San Antonio, Texas, United States and 35 other locations
(maintenance) in people with systemic lupus erythematosus (lupus), infantile spasms, adults with acute relapses or flares of multiple sclerosis...
Phase 2
San Antonio, Texas, United States and 2 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
San Antonio, Texas, United States and 225 other locations
The primary objectives are to investigate the safety and tolerability of BIIB091 monotherapy in participants with relapsing multiple sclerosis...
Phase 2
San Antonio, Texas, United States and 70 other locations
for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...
Phase 3
San Antonio, Texas, United States and 60 other locations
in male and female participants with relapsing forms of multiple sclerosis (aged 18 to 55 years at the time of enrollment). People ...
Phase 3
San Antonio, Texas, United States and 34 other locations
assess the safety, tolerability, and pharmacokinetics of single and multiple ascending oral doses of prosetin administered to healthy adult ...
Phase 1
San Antonio, Texas, United States
The purpose of this study is to evaluate long-term safety and efficacy of ublituximab therapy in participants with relapsing multiple sclerosis...
Phase 3
San Antonio, Texas, United States and 85 other locations
This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sc...
Phase 3
San Antonio, Texas, United States and 125 other locations
Clinical trials
Research sites
Resources
Legal